Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neonab: Tailored Neoadjuvant EC and Nab-Paclitaxel in Breast Cancer
NCT01830244Phase 2Unknown
- Sponsor
- Barwon Health
- Start
- Apr 2013
- Primary completion
- Sep 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Barwon Health. Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01830244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830244.